Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented

A Payton1, E van den Boogerd, Y Davidson

  • 1Centre for Integrated Genomic Medical Research, Stopford building, University of Manchester, Oxford road, Manchester, UK. tony@fs1.ser.man.ac.uk

Insights

Genetic variations in Cathepsin D (CTSD), APOE, and HLA-DRB1 influence cognitive abilities. The CTSD T allele negatively impacts processing speed and fluid intelligence, with interactions further affecting cognitive performance.

Area of Science:

  • Neuroscience
  • Genetics
  • Cognitive Science

Background:

  • Cathepsin D (CTSD), human leukocyte antigen DRB1 (HLA-DRB1), and apolipoprotein E (APOE) are linked to cognitive function.
  • CTSD processes proteins for HLA presentation, and its exon 2 polymorphism interacts with APOEε4, increasing Alzheimer's disease risk.
  • Previous research indicated CTSD exon 2 polymorphism affects fluid intelligence.

Purpose of the Study:

  • To investigate the association of CTSD exon 2 polymorphism with various cognitive domains in non-demented individuals.
  • To examine potential interactions between CTSD, APOE, and HLA-DRB1 in relation to cognitive performance.
  • To extend previous findings on CTSD and fluid intelligence to other cognitive functions.

Main Methods:

  • Analysis of a cohort of 766 non-demented volunteers.
  • Assessment of cognitive domains including processing speed, spatial recall, and fluid intelligence.
  • Genotyping for CTSD exon 2 polymorphism, APOE, and HLA-DRB1 alleles.

Main Results:

  • The CTSD exon 2 T allele was associated with decreased processing speed, spatial recall, and fluid intelligence.
  • HLA-DR1 showed association with enhanced cumulative recall, while HLA-DR5 was linked to diminished delayed verbal recall and spatial recall.
  • Interactions: CTSD T/APOEε4 positivity correlated with lower scores in fluid intelligence, processing speed, and immediate recall.
  • CTSD T/HLA-DR2 positivity was associated with reduced processing speed and significantly lower cumulative and spatial recall abilities.

Conclusions:

  • The CTSD exon 2 polymorphism significantly impacts multiple cognitive domains, including processing speed and fluid intelligence.
  • Epistatic interactions between CTSD and APOE, as well as CTSD and HLA-DR2, demonstrably affect cognitive performance.
  • These findings highlight the complex genetic underpinnings of cognitive ability and suggest potential biological mechanisms involving protein processing and immune response.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...